Summary and links to five landmark trials of intensive control vs standard therapy in DM2: UKPDS 33 - https://www.ncbi.nlm.nih.gov/pubmed UKPDS 34 - https://www.ncbi.nlm.nih.gov/pubmed VADT - https://www.ncbi.nlm.nih.gov/pubmed ADVANCE - https://www.ncbi.nlm.nih.gov/pubmed ACCORD - https://www.ncbi.nlm.nih.gov/pubmed #EBM #VisualAbstract #Endocrinology #PrimaryCare #Diabetes #DM2 #Type2 #Landmark #Trials #HgbA1c #Targets #Curbsiders